| Q43169995 | Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries |
| Q36839352 | Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes |
| Q37066018 | Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells |
| Q28379363 | Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues |
| Q42089071 | Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus |
| Q35027781 | Development of endothelin receptors in perinatal rabbit pulmonary resistance arteries |
| Q74261630 | Down-regulation of ET(B) receptor, but not ET(A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1? |
| Q43192104 | ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway. |
| Q28367973 | ETA receptor‐mediated constrictor responses to endothelin peptides in human blood vessels in vitro |
| Q38996325 | ETB-type receptors mediate endothelin-stimulated contraction in the aortic vascular smooth muscle of the spiny dogfish shark, Squalus acanthias |
| Q35043673 | Effect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia |
| Q26767156 | Endothelin |
| Q71955963 | Endothelin ET A and ET B Receptors Cause Vasoconstriction of Human Resistance and Capacitance Vessels In Vivo |
| Q34793212 | Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type |
| Q33709599 | Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension? |
| Q32065111 | Endothelin-1-induced potentiation of adrenergic responses in the rabbit pulmonary artery: role of thromboxane A(2). |
| Q71715277 | Endothelin-induced electrical activity and calcium dynamics in vascular smooth muscle cells: a model study |
| Q42580622 | EndothelinB receptor-mediated contraction in human pulmonary resistance arteries |
| Q33831069 | Endothelins and the lung |
| Q43181294 | Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia |
| Q38804579 | Lung Circulation |
| Q89344744 | Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension |
| Q35873974 | Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi |
| Q87288289 | New Diagnostic and Therapeutic Strategies for Pulmonary Hypertension Associated with Left Heart Disease |
| Q40601269 | Perinatal expression of heat shock proteins HSC 70 and HSP 70 in neural and non neural tissues of the piglet |
| Q48970085 | Perinatal expression of heat-shock protein 27 in brain regions and nonneural tissues of the piglet |
| Q40966671 | Pharmacology of A-216546: a highly selective antagonist for endothelin ET(A) receptor |
| Q72038057 | Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys |
| Q71776426 | Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lun |
| Q34525179 | Pulmonary hypertension secondary to left ventricular systolic dysfunction: contemporary diagnosis and management |
| Q37798155 | Pulmonary hypertension with left-sided heart disease |
| Q71378233 | Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract |
| Q43263003 | Regional modulation of cyclic nucleotides by endothelin-1 in rat pulmonary arteries: direct activation of G(i)2-protein in the main pulmonary artery. |
| Q24791936 | Role of endothelin-1 in lung disease |
| Q41976126 | Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery |
| Q71691553 | The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs |
| Q34981727 | The interaction of endothelin-1 and TGF-β1 mediates vascular cell remodeling |
| Q47775968 | The role of endothelin-1 as a mediator of the pressure response after air embolism in blood perfused lungs |
| Q71379667 | Tissue concentrations of endothelins and functional effects of endothelin-receptor activation in human arteries and veins |
| Q30650449 | Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation |